Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-059019
Filing Date
2014-09-22
Accepted
2014-09-22 16:43:48
Documents
2
Period of Report
2014-09-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6127
2 POA DOCUMENT poa.txt EX-24.3_539197 3479
  Complete submission text file 0001209191-14-059019.txt   10939
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Issuer) CIK: 0001340652 (see all company filings)

EIN.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CHEMOCENTRYX, INC. 850 MAUDE AVE. MOUNTAIN VIEW CA 94043
Business Address
Charo Israel (Reporting) CIK: 0001619515 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35420 | Film No.: 141114395